Alveolar, endothelial, and organ injury marker dynamics in severe COVID-19
DE Leisman, A Mehta, BT Thompson… - American Journal of …, 2022 - atsjournals.org
Rationale: Alveolar and endothelial injury may be differentially associated with coronavirus
disease (COVID-19) severity over time. Objectives: To describe alveolar and endothelial …
disease (COVID-19) severity over time. Objectives: To describe alveolar and endothelial …
[HTML][HTML] Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus
UK Katneni, A Alexaki, RC Hunt… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease of 2019 (COVID-19) is the clinical manifestation of the respiratory
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
Endothelial cells orchestrate COVID-19 coagulopathy
JM O'Sullivan, D Mc Gonagle, SE Ward… - The Lancet …, 2020 - thelancet.com
Recent data have shown that coagulation activation is common in patients with severe
COVID-19. 1, 2 Moreover, autopsy studies have reported widespread microthrombi …
COVID-19. 1, 2 Moreover, autopsy studies have reported widespread microthrombi …
von Willebrand factor multimer formation contributes to immunothrombosis in coronavirus disease 2019
AAN Doevelaar, M Bachmann, B Hölzer… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: Prevention and therapy of immunothrombosis remain crucial challenges in
the management of coronavirus disease 2019, since the underlying mechanisms are …
the management of coronavirus disease 2019, since the underlying mechanisms are …
[HTML][HTML] Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome
A Constantinescu-Bercu, A Kessler, R de Groot… - Journal of Thrombosis …, 2023 - Elsevier
Abstract Background Post-COVID syndrome (PCS) affects millions of people worldwide,
causing a multitude of symptoms and impairing quality of life months or even years after …
causing a multitude of symptoms and impairing quality of life months or even years after …
[HTML][HTML] VEGF-D: a novel biomarker for detection of COVID-19 progression
Y Kong, J Han, X Wu, H Zeng, J Liu, H Zhang - Critical Care, 2020 - Springer
As the coronavirus 2019 (COVID-19) continues to spread globally, hundreds of thousands
have been infected, among whom approximately 15% of COVID-19 patients develop severe …
have been infected, among whom approximately 15% of COVID-19 patients develop severe …
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
M Bazzan, B Montaruli, S Sciascia, D Cosseddu… - Internal and Emergency …, 2020 - Springer
Both arterial and venous thrombotic complications have been reported in patients affected
by COVID-19, especially in those critically ill. An emerging body of evidence is supporting …
by COVID-19, especially in those critically ill. An emerging body of evidence is supporting …
[HTML][HTML] ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
R Escher, N Breakey, B Lämmle - Thrombosis research, 2020 - ncbi.nlm.nih.gov
Emmental Hospital, situated in the rural town of Burgdorf in Switzerland, has treated a low
volume of inpatients with COVID-19. Of the 13 admissions prior to 30th April 2020, 4 …
volume of inpatients with COVID-19. Of the 13 admissions prior to 30th April 2020, 4 …
[HTML][HTML] ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
T Pascreau, S Zia-Chahabi, B Zuber… - Thrombosis …, 2021 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), may trigger cytokine storm which is responsible for a highly …
coronavirus 2 (SARS-CoV-2), may trigger cytokine storm which is responsible for a highly …
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
N Martinelli, M Montagnana, F Pizzolo… - Thrombosis …, 2020 - thrombosisresearch.com
The coronavirus disease 2019 is a global health pandemic emergency. The disease, named
coronavirus disease 2019 (COVID-19, SARS-CoV-2 infection) by the WHO, presents …
coronavirus disease 2019 (COVID-19, SARS-CoV-2 infection) by the WHO, presents …